These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 419108)

  • 41. [Effect of heterogenic blood and L-103 hydrolysin on calves].
    Sinkevich VA; Mogilenko AF
    Veterinariia; 1978 Feb; (2):91-3. PubMed ID: 636305
    [No Abstract]   [Full Text] [Related]  

  • 42. [Antitubercular activity and pharmacokinetics of rifampicin].
    Ginzburg TS; Drabkina RO
    Antibiotiki; 1972 Jul; 17(7):607-11. PubMed ID: 4655011
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of experimental tuberculosis in guinea pigs by continuous and intermittent regimen with special reference to ethambutol and rifampicin].
    Westfal I; Wiza J; Rudnicka M; Szymaczek-Meyer L
    Gruzlica; 1973 Jan; 41(1):1-8. PubMed ID: 4686876
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of rifampicin on experimental tuberculosis].
    Uvarova OA; Kozulitsyna TI; Korotaev GA
    Probl Tuberk; 1976 Jan; (l):65-70. PubMed ID: 995913
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pathomorphology of experimental tuberculosis induced by rifampicin-resistant mycobacteria].
    Vidin NB; El'shanskaia MP
    Probl Tuberk; 1972; 50(7):63-7. PubMed ID: 4626207
    [No Abstract]   [Full Text] [Related]  

  • 46. Experimental research on cycloserine.
    Panà C; Lenzini L
    Scand J Respir Dis Suppl; 1970; 71():76-85. PubMed ID: 5272005
    [No Abstract]   [Full Text] [Related]  

  • 47. [On the comparative effectiveness of rifampicin and INI treatment in guinea pigs inoculated with repeated microdoses of bacilli].
    Fabbrocini V
    Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):435-40. PubMed ID: 4984548
    [No Abstract]   [Full Text] [Related]  

  • 48. [Microscopic changes in liver in experimental tuberculosis in guinea pigs treated with rifampicin].
    Westfal I; Zengteler G; Szymaczek-Meyer L
    Gruzlica; 1974 Sep; 42(9):879-85. PubMed ID: 4410147
    [No Abstract]   [Full Text] [Related]  

  • 49. [Antituberculous activity of rifampicin for the experimental tuberculosis of guinea pigs].
    Toyoara M
    Kekkaku; 1970 Nov; 45(11):375-8. PubMed ID: 5484188
    [No Abstract]   [Full Text] [Related]  

  • 50. [Action of naganol on body protective mechanisms].
    Toshkov A; Georgiev D; Slavcheva E; Shirova L; Neĭchev Kh
    Acta Microbiol Bulg; 1980; 7():3-14. PubMed ID: 7340411
    [No Abstract]   [Full Text] [Related]  

  • 51. [Research on the protective action of rifampicin administered intermittently in experimental tuberculosis in guinea pigs].
    Algeorge G; Sibilla S; Rudesco D
    Ann Pediatr (Paris); 1970 Oct; 17(10):674. PubMed ID: 5475418
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of antibiotics on the activity of nonspecific humoral factors in mice and guniea pigs].
    Jakoniuk P
    Med Dosw Mikrobiol; 1981; 33(3-4):233-8. PubMed ID: 7346672
    [No Abstract]   [Full Text] [Related]  

  • 53. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Observations on antibody reaction scores on individual patients.
    O'Mahony MG
    Scand J Respir Dis Suppl; 1973; 84():64-72. PubMed ID: 4522079
    [No Abstract]   [Full Text] [Related]  

  • 54. Antigenic competition in guinea pigs through gingival inoculation of antigens.
    Sasaki S; Takazoe I
    Bull Tokyo Dent Coll; 1975 May; 16(2):59-68. PubMed ID: 799543
    [No Abstract]   [Full Text] [Related]  

  • 55. [Phagocyte functional activity and bactericidal systems after exposure to rifampicin, lincomycin and methicillin].
    Ratnikov VI; Nesterenko VG
    Antibiotiki; 1983 Jan; 28(1):44-8. PubMed ID: 6681946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
    Pallanza R; Arioli V; Furesz S; Bolzoni G
    Arzneimittelforschung; 1967 May; 17(5):529-34. PubMed ID: 5631580
    [No Abstract]   [Full Text] [Related]  

  • 57. [Some indices of the reactivity of the macroorganism in the use of ACS in the overall therapy of pulmonary tuberculosis].
    Taranenko MI; Smokvin VD
    Vrach Delo; 1975 Feb; (2):113-7. PubMed ID: 49129
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cytopathologic study of the thymus in experimental tuberculosis based on morphometric and cellular composition data].
    El'shanskaia MP
    Probl Tuberk; 1981 May; (5):58-63. PubMed ID: 7255392
    [No Abstract]   [Full Text] [Related]  

  • 59. [On the immunogenic activity at the level of the lymph nodes during BCG infection in quinea pigs].
    Lenzini L; Barnabè R
    Boll Soc Ital Biol Sper; 1969 May; 45(10):687-90. PubMed ID: 4923649
    [No Abstract]   [Full Text] [Related]  

  • 60. [Conditions for rifampicin activity and the formation of resistant Mycobacterium tuberculosis in in vitro experiments].
    Dolzhanskiĭ VM
    Probl Tuberk; 1982 Mar; (3):59-62. PubMed ID: 6806807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.